RAGE and modulation of ischemic injury in the diabetic myocardium
about
RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.Molecular Pathways Involved in the Amelioration of Myocardial Injury in Diabetic Rats by Kaempferol.The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureS100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent mannerAdvanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophagesSoluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and agingExendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expressionNuclear DAMP complex-mediated RAGE-dependent macrophage cell death.Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal TransductionMitochondrial ROS Induces Cardiac Inflammation via a Pathway through mtDNA Damage in a Pneumonia-Related Sepsis Model.Oxidative stress contributes to the impaired sonic hedgehog pathway in type 1 diabetic mice with myocardial infarction.Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injuryInsulin resistance: metabolic mechanisms and consequences in the heart.Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation.Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory responseThe receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammationNon-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer.Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.Advanced glycation end products: role in pathology of diabetic cardiomyopathy.Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Maillard reaction in food allergy: Pros and cons.Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.Glycation & the RAGE axis: targeting signal transduction through DIAPH1.Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas.Effects of dietary arginine on inflammatory mediator and receptor of advanced glycation endproducts (RAGE) expression in rats with streptozotocin-induced type 2 diabetes.Stopping the primal RAGE reaction in myocardial infarction: capturing adaptive responses to heal the heart?Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.Tiron ameliorates high glucose-induced cardiac myocyte apoptosis by PKCδ-dependent inhibition of osteopontin.Hyperglycemia and liver ischemia reperfusion injury: a role for the advanced glycation endproduct and its receptor pathway.A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathway.Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.Perspectives on RAGE signaling and its role in cardiovascular disease.S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
P2860
Q33559727-8176B51B-38E6-4D72-8C05-3A4E96CB021DQ33755103-2F3E7FF0-7F1B-4EA9-AD0D-17DDA5D67A94Q33822512-2C527D79-4B24-400B-BB68-01540B15F29FQ33939707-DF3E62EB-E715-4CEF-B9B2-2067054DB848Q34003967-AEF34BE8-FE3D-403C-BFD3-00BD47BECCBBQ34094369-8A273241-B368-4600-ADCB-D53CCB5980D6Q34119534-4480DF05-9917-4D98-81A8-DFD156993AABQ35164703-91B866E7-0A46-4199-8FF5-9A9823930265Q35943768-2195DA45-3FCF-497D-966E-A24F68E4F7FCQ36137078-7A52BEA5-A97E-40CD-8426-10CA6EECC578Q36336214-0349DB89-F6D3-493D-B15E-DF7F6989E5DBQ36795745-ECBAA568-DF00-48C5-89DB-6496163907B5Q36821424-7E5FC31C-9BE2-4066-B2FA-DBEDE3F96CFBQ37291206-8956CB54-C65D-415F-B08F-CEDB4753E9F9Q37318895-F74A51A1-3DE8-43C7-A213-5D99A9025E3EQ37384331-34264C49-5102-41B9-9CC1-ADB676F77953Q37412673-483A7B38-8659-4DCC-BE3E-28E736494C3EQ37424029-34E0F7FA-8B2B-4A30-89D3-DE74CBEEF44AQ37825897-5FCFD0E8-6214-4EFB-8F76-07E9EBD922C1Q37972674-326F7575-4584-42E9-92B7-5EB5BB252CE2Q37997993-CC3FACA9-0072-41CD-B0FB-68CA2538B7FAQ38023062-F36C998C-535B-4E69-B41A-6760E0F5F1AEQ38081119-4817C39E-EB39-4210-8E2B-340AA7128E09Q38430098-8429EFFB-FDCB-4783-9C74-F3A59C89529CQ38620860-BB09C325-C500-42FE-A0E7-3ADD58542DC7Q38776099-B5A8ECEF-9DA8-4D6A-87F8-D1B4813B690DQ38859313-C5BDB48F-E0F0-4BC5-8FDD-59D249BE867FQ39038218-6E1DBA32-F658-4F37-8965-3690006B61CDQ39436295-7B10F418-BFC8-4444-9D13-D4ACF4D518B8Q41110486-43EE2FBB-0BFC-4B71-9374-3404D0E3137EQ43101263-AD66C4D5-7A3F-4A26-B810-EBD391994C8CQ43103840-7C8EDDE6-9C9C-42E1-9553-2845BE693136Q46034115-79F838C0-6BBA-48E7-B0EC-FEDFB56EF3A5Q46386818-507C58EB-7074-4751-8231-0C6A1E96508EQ46807012-C0FBF123-71C1-481D-924C-E1491AB1778BQ50215120-8DE00199-3E7C-4EDB-BCDB-C2D8A814CC78Q50568735-CE981B1B-743C-4CF2-81E1-3D96DE1017ACQ52642353-55986902-AF2F-471A-A479-99C511272FAEQ53344878-C1728C1D-4DC1-4523-82D2-FDBBB615BB0AQ54325092-09E6772F-D208-42EA-9AA8-8556EB234029
P2860
RAGE and modulation of ischemic injury in the diabetic myocardium
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
RAGE and modulation of ischemic injury in the diabetic myocardium
@ast
RAGE and modulation of ischemic injury in the diabetic myocardium
@en
type
label
RAGE and modulation of ischemic injury in the diabetic myocardium
@ast
RAGE and modulation of ischemic injury in the diabetic myocardium
@en
prefLabel
RAGE and modulation of ischemic injury in the diabetic myocardium
@ast
RAGE and modulation of ischemic injury in the diabetic myocardium
@en
P2093
P2860
P356
P1433
P1476
RAGE and modulation of ischemic injury in the diabetic myocardium
@en
P2093
Ann Marie Schmidt
Christopher Strauch
David R Sell
Loredana G Bucciarelli
Michiyo Kaneko
Radha Ananthakrishnan
Ravichandran Ramasamy
Shi Fang Yan
Vincent M Monnier
P2860
P304
P356
10.2337/DB07-0326
P407
P577
2008-04-16T00:00:00Z